AUA 2017: Surgeon-specific variation for outcomes after benign prostatic hyperplasia surgery

Boston, MA ( Under the presumption that surgeon experience effects patient outcomes following the surgical treatment of BPH, Weaver et al. performed a retrospective chart review comparing 7 surgeons at their institution to determine whether surgeon-specific variation effects BPH outcomes. They reviewed 184 patient charts for those who underwent BPH surgery between 2008 and 2016. As a means to compare the treatment effect on these patients, they defined success as an AUA symptom score < 8 and no use of BPH medications at 4 months, both postoperatively.

Multivariate analysis indicated that the surgeon performing the procedure a predictor of successful BPH treatment. Some attendees felt that the definition used for success were ignoring some of the important factors to consider regarding BPH treatment, including morcellation rate, recurrence of symptoms, operative times, complications, and et cetera. The principal investigator for this study, Dr. Strope, responded that the goal was to report a generalizable set of variables versus all potential factors; upon their chart review, they found that AUA symptom score and use of BPH medication are both are documented in all BPH surgeries, and the other factors were not as readily identified. He also noted that this is a limitation in their study and one they intend to address in a prospective study.

Authors: John Weaver, Joel Vetter, Eric Kim, Niraj Badhiwala, Seth Strope

Affiliation: Division of Urology, Department of Surgery, Washington University School of Medicine, and Urologic Oncology, Baptist MD Anderson Cancer Center

Presented by: John Weaver

Written By: Shoaib Safiullah, MS4 for

at the 2017 AUA Annual Meeting - May 12 - 16, 2017 – Boston, Massachusetts, USA